Public Health Vaccines LLC

A US-based vaccine development company awarded $1.9m by CEPI on 9 June 2026 to generate master viral seed stock for a fourth Bundibugyo ebolavirus vaccine candidate on the rVSV platform.

1 of 1 entries (1 events, 0 interactions)